SEC Form D · filed May 11, 2015
Adaptive Biotechnologies Corp
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (29)
Arnold Levine · SEATTLE, WADirectorRob Rosen · SEATTLE, WADirectorRob Hershberg · SEATTLE, WADirectorAndris Zoltners · SEATTLE, WADirectorPeter Neupert · SEATTLE, WADirectorDean Schorno · SEATTLE, WAExecKathleen Determann · SEATTLE, WAExecChad Robins · SEATTLE, WAExec · DirectorTom Willis · SEATTLE, WADirectorJohn Stuelpnagel · SEATTLE, WADirectorJustin Mahoney · Stamford, CTDirectorPaul A. Mahon · Winnipeg, Manitoba, CanadaDirectorDennis Moon · Atlanta, GAExecLeonard Dipietra · New York, NYExecJoshua D. Rand · New York, NYExec · DirectorJeffery Wright · Atlanta, GADirectorNicole Rothschild · New York, NYDirectorChad Cohen · Seattle, WADirectorSamer Atiani · Rego Park, NYDirectorScott Haufe · Atlanta, GADirectorJames Andrews · Atlanta, GAExec · DirectorPatrick Kullman · Atlanta, GAExecJarrett Gorlin · Atlanta, GADirectorC.A. Hennies · Atlanta, GAExec · DirectorLarry Papasan · Atlanta, GADirectorGregory D. Tretiak · Winnipeg, Manitoba, CanadaDirectorSiim A. Vanaselja · Winnipeg, Manitoba, CanadaDirectorAndrew D. Brands · Winnipeg, Manitoba, CanadaDirectorChad Cohen · SEATTLE, WADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗